Clinical trial
Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study
NCT03732625 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study
- Lead sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2019
- Completion date
- January 31, 2021
- Enrollment
- 50 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.